Evofem Biosciences (EVFM) Misses Q3 EPS by 1c

Evofem Biosciences (OTC: EVFM) reported Q3 EPS of ($0.01). Revenue for the quarter came in at $4.95 million.

For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.

You May Also Be Interested In

• Electra Therapeutics files for proposed IPO
• Nomura/Instinet Upgrades Zeon Corp (4205:JP) (ZEOOF) to Buy
• Nomura/Instinet Starts Clean Max Enviro Energy Solutions (CLEANMAX:IN) at Buy